Stimulant ADHD Meds Work Differently Than Experts Assumed

Approximately 3.5 million children in the USA, ages 3-17, take attention-deficit/hyperactivity disorder (ADHD) medications, most commonly stimulants. These include methylphenidate (e.g., Ritalin, Concerta) and amphetamine-based medications like lisdexamfetamine (Vyvanse) or Adderall. For decades, pediatricians and psychiatrists assumed these drugs improved ADHD symptoms and learning by enhancing attention, particularly by increasing dopamine and norepinephrine.

Prescription stimulants, classified as Schedule II controlled substances, are also assumed to be cognitive enhancers—drugs that make almost anyone think more clearly. This belief has fueled decades of ethical debates about unfair advantages in standardized testing and widespread nonmedical use among students. Adolescents without ADHD often seek these medications from peers with prescriptions, assuming they will improve academic performance. However, behavioral and neuroimaging evidence suggest these assumptions are incorrect.

New Brain Study

Washington University in St. Louis researchers analyzed brain imaging and behavioral data from 5,795 children, ages 8-11, from the Adolescent Brain Cognitive Development (ABCD) study, who took prescription stimulants the day of their brain scan. Researchers found stimulants altered brain networks related to arousal, wakefulness, and reward valuation rather than increasing activity in attention networks.

Compared with children not taking stimulants, those who took them showed increased functional connectivity in brain regions associated with alertness and predicting how rewarding a task will be. In contrast, there was no significant increase in activity in regions classically associated with attention control.

Stimulant medications apparently increased the perceived reward value of tasks, enabling children to persist in activities that otherwise felt tedious or impossible for them to complete. Rather than directly “activating” attention circuits, ADHD medications may make reading or math feel more rewarding, thereby improving attention and task engagement. By increasing motivation and reducing perceived effort, stimulants also may calm hyperactivity, as children are less likely to disengage, fidget, or become restless during previously aversive tasks.

Significantly, stimulant use was associated with better academic outcomes only in children with ADHD and/or the sleep-deprived. Well-rested children without ADHD did not show improved academic performance with stimulant use, emphasizing the importance of sleep. These new findings reinforce the need to evaluate and treat sleep deprivation before diagnosing ADHD or initiating stimulants.

In my prior Psychology Today post examining whether Ritalin and other psychostimulants improve thinking, I argued these drugs are widely misunderstood as “smart drugs.” Instead, they tend to optimize performance under specific conditions—remarkably low baseline performance, fatigue, or motivational deficits. The new study provides neurobiological evidence supporting this interpretation.

Contrary to popular belief, psychostimulants work by enhancing wakefulness and willingness to engage in tasks that might otherwise feel uninteresting or require too much effort. This helps explain a long-standing paradox: Individuals taking stimulants often feel mentally sharper even when objective measures of cognition show minimal or no improvement.

Importance of Sleep

One of the most important findings of the new study is that prescription stimulants appear to mimic brain connectivity patterns associated with being well-rested, effectively reversing some effects of sleep deprivation. Stimulants normalized arousal-related networks in a way that resembled attainment of adequate sleep.

ADHD Essential Reads

The Impossible Benchmark: Who Does Not Have ADHD?

'You Don’t Outgrow ADHD and You Don’t Outlast It'

WashU co-author and pediatric neurologist Benjamin Kay, MD, PhD, noted that insufficient sleep is particularly harmful for children. Overtired children may exhibit classic ADHD symptoms, including difficulty sustaining attention, behavioral dysregulation, and declining academic performance. In some cases, this may lead to an invalid ADHD diagnosis when the underlying problem is actually chronic sleep deprivation.

Stimulants do not directly strengthen attention systems; instead, attention improvements are secondary effects of increased alertness and enhanced reward valuation. When children are more awake and tasks feel more rewarding, they naturally pay better attention.

Stimulants also tend to normalize performance, often bringing children with ADHD or sleep deprivation closer to baseline functioning rather than pushing them above it. Well-rested, high-functioning individuals without ADHD generally do not benefit from stimulants, particularly tasks they already find engaging or rewarding. In situations requiring creativity, flexibility, or complex reasoning, stimulants may confer little benefit and can even impair performance or inflate confidence without improving accuracy.

ADHD medications do not raise cognitive ceilings; instead, they compensate for deficits in arousal, motivation, or sleep. Their effects resemble “being well-rested,” not “being smarter.”

The new WUSTL paper provides missing neurobiological evidence that psychostimulants improve thinking only when thinking is impaired by fatigue, low motivation, or reduced arousal. These medications help individuals do what they already can do—but struggle to do under suboptimal conditions—rather than granting new cognitive abilities.

When taken as prescribed, ADHD medications produce moderate, gradual changes in dopamine signaling, improving behavior and attention without the intense euphoria or addiction. Consistent with this, individuals appropriately treated for ADHD have lower rates of substance abuse over time.

Stimulants primarily increase wakefulness, motivation, and task engagement. In individuals already well-rested and cognitively intact, objective improvements in cognition are inconsistent, minor, or absent, despite subjective reports of enhanced focus. Performance on sustained tasks depends not only on cognitive ability but also on vigilance, energy, and perceived reward. Stimulants reliably enhance these factors but do not raise upper limits of reasoning, learning, or judgment.

ADHD Stimulants vs. Methamphetamine

Although ADHD medications and methamphetamine are both classified as stimulants, they differ profoundly in abuse potential. Methamphetamine-related mortality has intensified nationally, often associated with smoking or injecting in combination with fentanyl. The most crucial determinant of this difference is how quickly the drug reaches the brain.

A core principle of addiction neuroscience is that smoking and injection have a faster onset and confer higher abuse liability. Methamphetamine is typically used via rapid-delivery routes, often at very high, unsupervised doses, dramatically increasing addiction risk. When stimulants are smoked, injected, or snorted, they produce large, abrupt spikes in dopamine that strongly reinforce repeated use.

In contrast, prescription ADHD stimulants are designed for slow, controlled delivery. When taken orally as prescribed, absorption is gradual, leading to modest, steady increases in dopamine and norepinephrine. These changes support sustained attention, motivation, and behavioral regulation without euphoria. Many ADHD medications are formulated as extended-release preparations to further slow delivery and reduce rapid dopamine spikes, thereby lowering misuse potential.

While misuse of prescription stimulants does occur—particularly among adolescents and college students seeking academic enhancement—risk is higher with immediate-release formulations and non-oral routes of administration. Consistent with addiction research, misuse correlates strongly with how quickly a drug produces noticeable effects.

Conclusion

Psychostimulants are best understood as performance enhancers rather than cognitive enhancers. They improve performance by increasing effort, alertness, reaction time, task persistence, and tolerance for boredom. Successfully treating ADHD has the additional effect of decreasing risks for substance use disorders.